<DOC>
	<DOCNO>NCT00772759</DOCNO>
	<brief_summary>The primary objective study investigate safety tolerability single multiple daily ascend dos AZD3199 deliver dry powder via Turbuhaler inhaler healthy male Japanese subject assessment incidence nature adverse event ( AEs ) , clinically significant abnormality ECG parameter , blood pressure ( BP ) , pulse rate , lung function parameter , body temperature laboratory variable ( clinical chemistry , haematology urinalysis ) . The secondary objective study investigate pharmacokinetics ( PK ) single multiple ascend dos AZD3199 assessment degree accumulation , dose proportionality time linearity healthy Japanese subject , investigate systemic Î² 2- adrenoreceptor mediate effect single multiple ascend dos AZD3199 assessment potassium lactate concentration , tremor palpitation , heart rate , QTc , pulse rate , blood pressure FEV1 .</brief_summary>
	<brief_title>Assess Safety , Tolerability PK AZD3199 Japanese</brief_title>
	<detailed_description />
	<mesh_term>AZD-3199</mesh_term>
	<criteria>Be healthy Japanese volunteer , volunteer 's parent , grandparent must Japanese . The volunteer must bear Japan , valid Japanese passport must live outside Japan 5 year . BMI 18 27 , Weight 50 85 kg Be nonsmoker exsmoker stop smoke ( use nicotine product ) &gt; 6 month prior study start . Clinical normal physical finding Any clinically significant disease disorder Any clinically relevant abnormal finding physical examination , clinical chemistry , haematology , urinalysis , vital sign , ECG lung function baseline Any clinically important abnormality rhythm , conduction morphology rest ECG may interfere interpretation QTc interval change . Use medication ( include OTC ) , herbal preparation , vitamin nutritional supplement within 2 week prior Visit 2 , except occasional intake paracetamol ( maximum daily dose 4 g )</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>AZD3199</keyword>
	<keyword>Japanese Healthy Volunteers</keyword>
	<keyword>Phase I study</keyword>
	<keyword>Single Multiple Ascending Dose</keyword>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>PK</keyword>
</DOC>